Genome Medical

Named as a key player in 33 of our reports, across 33 regions and countries.

Genome Medical's markets

1

Markets where they are a key player. Each opens the market's statistics for every place we cover.

Healthcare Services1

Recent reports naming Genome Medical

Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.

All 33 reports

Companies they compete with most

Named as key players in the same markets as Genome Medical (number of shared markets).

Public data

Free public data on Genome Medical

From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.

About our sources

Trials over time

Studies Genome Medical leads, by the year they started and their phase

  • Phase 1
  • Phase 2
  • Phase 3
  • Phase 4
  • No phase (devices, observational)

Source: ClinicalTrials.gov, Studies with Genome Medical or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.

Topics

The topics of the markets Genome Medical is in.

All topics

Search all reports for Genome Medical All companies